| 000 | 01122nam a22002417a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20260812091553.0 | ||
| 008 | 260708t2025 |||||||| |||| 00| 0 eng d | ||
| 020 | _a9781837402847 | ||
| 050 |
_aAllied KF 3885 _bM43 2025 |
||
| 100 | 1 | _aOliver Medina | |
| 245 | 1 | 0 |
_aPharmaceutical regulatory affairs / _cOliver Medina. |
| 264 |
_aUnited Kingdom : _bPrimed Publishing, _c2025. |
||
| 300 |
_aviii, 204 pages : _bcolored illustration ; _c29 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 500 | _aIncludes index | ||
| 505 | 0 | _ach. 1. Introduction to pharmaceutical regulatory affairs. -- ch. 2. Drug development and regulatory pathways. -- ch. 3. International regulatory agencies. -- ch. 4. Regulatory submissions and documentation. -- ch. 5. Post-market surveillance and pharmacovigilance. -- ch. 6. Regulatory affairs for generic and biosimilar products. -- ch. 7. Emerging trends in pharmaceutical regulations. | |
| 650 | 0 |
_aPharmacy _xLaw and legislation |
|
| 650 | 0 |
_aDrugs _xLaw and legislation |
|
| 942 |
_2lcc _cBK _kEAC Cavite-Allied |
||
| 999 |
_c100048 _d100048 |
||